Thermo Fisher: $17.4b PPD buy ‘natural extension’ for pharma
The chairman, president and CEO of Thermo Fisher says the acquisition stands to benefit clinical trial and drug development clients in a long list of ways.
Archives for April 26, 2021
Study examines solution to gauge adverse drug event risk
Published by Tabula Rasa Healthcare, the report looks at the MedWise Risk Score, technology designed to determine ADE risk rising from medication regimens.
CRAACO
CRAACO tackles ways to strengthen care, patient connection
The 6th annual Clinical Research as a Care Option conference, taking place April 26-27, brings together experts seeking solutions to elevate the industry.